Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Under Armour Inc Class A (UAA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Under Armour Inc Class A — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B), while Under Armour Inc Class A trades at $4.93 (market cap $2.07B). The key difference: SELLAS Life Sciences Group Inc. Common Stock and Under Armour Inc Class A are close in size by market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.
| SLS | UAA | |
|---|---|---|
Market Cap | $2.27B | $2.07B |
Volume | 4,179,659 | 12,050,442 |
Sector | Health | Consumer Cyclical |
52-Week High | $15.46 | $8.14 |
52-Week Low | $1.39 | $4.17 |
Enterprise Value | $2.14B | $3.05B |
Typical Hold Time | — | 99 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Under Armour (UAA) trades at $4.88, up 1.24% with a mixed technical picture showing bullish moving averages but neutral oscillators. The company faces fundamental challenges with negative net income margins (-9.99%) and declining revenue trends, though valuation metrics like P/S (0.42) appear attractive. Recent news highlights brand transformation efforts amid softer demand, with the company maintaining profitability outlook despite revenue cuts.
The outlook remains cautious with significant execution risks as Under Armour navigates weak consumer spending. Analyst consensus shows modest upside to the $5.79 price target, but persistent revenue declines and negative cash flow trends pose substantial headwinds for shareholder value recovery in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Under Armour Inc Class A
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →
